ACUTE SEVERE ASTHMA IN CHILDREN
ROLE OF INTRAVENOUS MAGNESIUM SULFATE IN TREATMENT
DOI:
https://doi.org/10.29309/TPMJ/2015.22.08.1152Keywords:
Acute severe asthma, children, intravenous magnesium sulfate, conventional treatment, efficacyAbstract
Objective: To compare the efficacy of intravenous magnesium sulfate and
conventional treatment with conventional treatment alone in acute severe asthma in children of
age group 5 to 15 years known cases of bronchial asthma. Study design: Randomized control
trial. Setting: Indoor and outdoor patients of pediatrics department of DHQ hospital, Faisalabad.
Duration: Six months. Results: In this study, 43.58%(n=17) in Exposed and 53.85%(n=21) in
Un-exposed group were male and remaining 56.42%(n=22) and 46.15%(n=18) were females,
mean pulse rate in both groups was recorded which shows 97.32+6.58 in Exposed Group
and 103.67+8.32 in Un-exposed Group, p value was calculated as 0.02, mean FEV1 rate in
both groups was recorded which shows 60.32+7.56 in Exposed Group and 54.07+6.43 in Unexposed
Group, p value was calculated as 0.03. Conclusion: We concluded that intravenous
magnesium sulfate along with conventional treatment is significantly better than conventional
treatment alone for the management of acute severe asthma attack.
